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Abstract
Background: The aetiology of colorectal cancer has strong dietary links, and there may be an association
between coffee and colorectal cancer risk.
Objective: To study the effects of filtered (low levels of kahweol/cafestol) and unfiltered (high levels of
kahweol/cafestol) coffee on tumour formation in multiple intestinal neoplasia (Apc
Min/) mice.
Design: Apc
Min/ mice (n11 per group) were fed for 9 weeks with 10% w/w of these two types of coffee.
Coffee was served as a dietary ingredient mixed with a semi-synthetic AIN-93G-based diet. Plasma levels of
caffeine and paraxanthine were used as compliance markers. At the end of the feeding period intestinal
tumour number and size were determined. The levels of b-catenin and cyclin D1, two cell-signalling proteins
important to the progression of neoplasia, were also analysed in the tumour tissue.
Results: Plasma caffeine and paraxanthine concentrations were 3.291.4 and 1.790.4 mmol l
1 in the filtered
coffee group and 3.692.3 and 1.690.6 mmol l
1 in the unfiltered coffee group. The level of plasma xanthines
was below detection in the control group. The total number of tumours was equal between the dietary groups:
29 for the control, 30 (p0.767) for the filtered coffee and 29 (p0.430) for the unfiltered coffee groups. The
levels of b-catenin and cyclin D1 in the nuclear fraction of the tumour tissue were also the same between the
groups.
Conclusions: Filtered or unfiltered coffee (10% w/w) does not exert antitumorigenic activity in Apc
Min/ mice
or change b-catenin and cyclin D1 signalling in the adenoma tissues. The results suggest that coffee does not
change neoplasia progression in this animal model.
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Introduction
C
olorectal cancer (CRC) is the third most
common cancer worldwide (1). It occurs
mainly sporadically and environmental fac-
tors, including diet, are strongly implicated in its
aetiology (2). Diets high in vegetables, fruits, and
perhaps fibre, or low in fat and red meat, have been
suggested to be associated with a decreased risk of
CRC. The association between coffee and CRC risk
is a matter of controversy. The pooled results of 12
casecontrol studies showed a significant 28%
reduction in CRC risk for a high versus low
category of coffee consumption [pooled relative
risk (RR)0.72, 95% confidence interval (CI)
0.610.84] (3). In addition, a meta-analysis, includ-
ing five cohort and the above-mentioned 12 case
control studies, reported a significant pooled rela-
tive riskof 0.76 (95% CI 0.660.89) for a high versus
low category of coffee consumption. However, a
review of casecontrol studies showed inconsistent
results between the coffee consumption and the risk
of colon cancer (4). Cohort studies have not shown
any reduction in CRC risk associated with coffee
(36).
Animal studies on the effects of coffee constitu-
ents, such as caffeine, kahweol and cafestol, on
colon tumorigenesis, have also shown conflicting
results. Administration of caffeine at 0.1% level in
drinking water enhanced heterocyclic amine-in-
duced aberrant crypt number (7) and DNA adduct
formation in the rat colon (8). Caffeine at a dose of
0.044% in drinking fluid had no inhibitory effect on
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Apc
Min/ mice (9). In contrast, coffee oil and its
major constituents, kahweol and cafestol, decreased
the adenocarcinoma frequency in the colon of 1,2-
dimethylhydrazine-treated rats, and inhibited the
formation of mutagen-DNA adducts in the colonic
mucosa (10, 11). Data obtained from animal studies
and human interventions indicate that some puta-
tive chemopreventive mechanisms of coffee and its
components could be related to the induction of
several phase II xenobiotic metabolizing enzymes
such as glutathione S-transferase and N-acetyl-
transferase, and protection against DNA damage
caused by mutagens (1116).
Colon carcinogenesis can be studied either by
inducing aberrant crypt foci or tumour formation
with chemical carcinogens or by using mouse
models with defects in the Apc gene. One such
mouse model for human familial adenomatous
polyposis (FAP) is multiple intestinal neoplasia
(Apc
Min/) mouse (17). Apc
Min/ mice have a point
mutation in the Apc allele, which in turn causes
truncated Apc protein formation. Mutations in the
APC/Apc gene lead to the accumulation of hypo-
phosphorylated b-catenin protein in the cytosol and
later in the nucleus, where b-catenin together with
transcription factors (18) constitutively activate the
expression of target genes such as C-myc and cyclin-
D1 (19, 20). Mutations in the APC gene predispose
people to CRC, whereas in Apc
Min/ mice, owing to
their short lifespan, most of the tumours are benign
adenomas. This experiment studied the possible
chemopreventive effect of filtered or unfiltered
coffee (10% w/w) on tumour formation in Apc
Min/
mice. Both filtered and unfiltered coffees contain
caffeine, but the concentration of kahweol and
cafestol depends on brewing methods (21). Unfil-
tered coffee, which represents the traditional type of
coffee consumed particularly in Scandinavia, con-
tains cafestol and kahweol, whereas filtered coffee
mostly lacks these compounds.
Materials and methods
Animal experiment
C57BL/6JApc
Min/ mice were bred at the Labora-
tory Animal Centre of the University of Helsinki,
Finland. Mice positive for the Apc
Min/ genotype,
as determined by polymerase chain reaction (PCR)
amplification of weaning tail biopsy DNA (22),
were assigned randomly to the experimental diets at
a mean age of 3492 days (5 weeks) with 11 mice per
group. Each diet group contained seven males and
four females. Animals were housed in plastic cages
in a temperature- and humidity-controlled animal
facility, with a 12 h light/dark cycle. They had free
access to the experimental semi-synthetic diets and
tap water for the feeding period of 9 weeks. Fresh
diets were provided four times per week. Body
weights were recorded weekly. The experimental
protocol was approved by the Laboratory Animal
Ethics Committee of the University of Helsinki.
Diets
All the experimental diets were semi-synthetic AIN-
93G-based (23) high-fat diets. The fat concentration
(20 g per 100 g) and fat composition of the experi-
mental diets were designed to approximate those in
a typical Western-type diet; the diet provided
intakes of saturated, monounsaturated and poly-
unsaturated fatty acids in an approximate ratio of
3:2:1 (24). Three diets were included: a control diet,
a filtered coffee diet (10% w/w) and an unfiltered
coffee diet (10% w/w). All diets were similar with
respect to protein (20%), fat (40%) and carbohy-
drates (40%) on an energy basis (kJ). The filtered
coffee was prepared in a regular procedure by
adding 14 g of coffee per 1.25 dl (1 cup) of water
and using a paper filter. The unfiltered coffee was
prepared by boiling ground coffee beans with water
(14 g of coffee per 1.25 dl). After cooling, the
unfiltered coffee was decanted. The coffee diets
were prepared by adding to the control diet 10%
(w/w) of filtered or unfiltered coffee beverage.
Coffee was served as a dietary ingredient and not
a drink because it was found that coffee drink
separated into layers in a drinking bottle. Food
consumption per mouse was estimated to be 2.4 g
per day. Therefore, the estimated amount of coffee
consumed per body weight of the animals was
approximately equivalent to 0.6 litres per day for
humans. The composition of the experimental diets
is shown in Table 1.
Intestinal tumour scoring and tissue samples
At the age of 14 weeks, the mice were killed by
carbon dioxide asphyxiation. Blood was collected
from the caudal vena cava into heparinized tubes
and centrifuged at 6000g for 1 min, after which
plasma was stored at 708C. The small intestine,
caecum and colon were removed, opened along
the longitudinal axis and rinsed with ice-cold saline.
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equal length. The caecum and colon were kept
together. The small intestine and colon and caecum
were then spread flat on a microscope slide. The
number, diameter and location of intestinal tumours
were determined with an inverse light microscope
with a magnification of 67 by two observers blind
to the dietary treatment. The minimum detection
limit of the adenoma diameter was 0.3 mm. Ade-
noma tissue was excised, and the normal-appearing
mucosa tissue was scraped. Tissues were snap-
frozen in liquid nitrogen and stored at 708Cf o r
further analysis.
Plasma xanthine analysis
Plasma concentrations of caffeine, paraxanthine,
theophylline and theobromine were determined to
verify coffee intake. The analyses were performed by
a new method based on liquidliquid extraction
and high-performance liquid chromatography
(HPLC). Fifty microlitres of plasma was incubated
with 5 mlo fb-glucuronidase/sulfatase solution,
10 mM of ascorbic acid and 85 mM of sodium
acetate for 18 h to cleave potential glucuronide and
sulfate conjugates. Fifty microlitres of sodium
acetate buffer (0.7 M, pH 2) and 1 ml of ethyl
acetate were added, and xanthines were extracted
into the upper phase during thorough mixing. The
procedure was repeated three times, whereafter the
upper phases were combined and dried down under
nitrogen. The dried sample was dissolved into the
HPLC mobile phase. Xanthines were then separated
by HPLC. The equipment consisted of Agilent 1100
Series components including quaternary pump,
autosampler, degasser and variable-wavelength
ultraviolet (UV) detector (Palo Alto, CA, USA).
Chromatographic separations were achieved using
an Agilent Eclipse XDP-C18 (5 mM, 4.6150 mm)
(Palo Alto, CA, USA). The mobile phase consisted
of 15% methanol in 10 mM sodium acetate buffer
(adjusted to pH 5 with orthophosphoric acid). The
flow rate was set at 1.5 ml min
1 and the wave-
length at 274 nM. The recovery levels of the four
xanthines were  90%. Intra-assay and interassay
precision was below 4% and 9%.
Western blot analysis
The adenoma tissues of the small intestine were
fractionated into nuclear, cytosolic and membra-
nous fractions as described by Pajari et al. (24) for
Western blot analysis. Normalized amounts of the
nuclear proteins (510 mg), and constant amounts of
rat brain or TMK (a human gastric cancer cell)
homogenate (controls for interassay variation) were
resolved by 10% sodium dodecyl sulfatepolyacry-
lamide gel electrophoresis (SDS-PAGE), and each
samplewas run twice, the duplicates being loaded on
a different gel. The proteins were blotted onto a
nitrocellulose membrane (Hybond ECL; Amersham
Pharmacia Biotech, UK) at 100 V for 1 h, and blots
were blocked with 5% non-fat milk powder in Tris-
buffered saline containing 0.1% Tween (TBS-Tween)
overnight at 48C. Antibodies against b-catenin
(sc-7199) and a horseradish peroxidase (HRP)-
conjugated secondary antibody (sc-2030) were pur-
chased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Cyclin D1 was from NeoMarkers (Lab
Vision, Fremont, CA, USA). The blots were first
probed with the primary antibodies for 2 h at room
temperature, washed three times with TBS-Tween
and incubated with the HRP-conjugated secondary
antibody for 2 h. Signalswerevisualized byusing the
ECL reagents and film (Amersham Corporation,
Arlington Heights, IL, USA) according to the
manufacturer’s instruction. Specificities of signals
were verified either with incubations without appro-
priate primary antibody or by using a blocking
peptide provided by a supplier (Lab Vision,
Fremont, CA, USA). The specificityof the b-catenin
bands was ensured earlier by using two other
commercially available antibodies (24). Blots were
scanned and analysed using a GS-800 Calibrating
Table 1. Composition of experimental diets (g kg
1 diet)
a
Ingredient Control Filtered coffee Unfiltered coffee
Casein 236.2 212.6 212.6
Dextrose 479 431.1 431.1
Butter 148.9 134.0 134.0
Sunflower oil 13.3 12.0 12.0
Rapeseed oil 62.2 56.0 56.0
Mineral mix AIN-93-MX 41.6 37.4 37.4
Vitamin mix AIN-93-VX 11.8 10.6 10.6
L-cystine 3.6 3.2 3.2
Choline chloride 3.6 3.2 3.2
Tert-butylhydroxyquinone 0.014 0.014 0.014
Coffee
b 100 100
aCasein was obtained from Kainuun Osuusmeijeri (Sotkamo, Finland), dextrose
from Six Oy (Helsinki, Finland), mineral and vitamin mix from Harlan Teklad
(Madison, WI, USA), l-cystine, choline chloride and tertiary butylhydroxyquinone
from Yliopiston Apteekki (Helsinki, Finland). Butter, sunflower oil, rapeseed oil
and ground coffee beans for filtered and unfiltered coffee were from a local
market.
bSee Materials and methods.
Tumour formation in Apc
Min/ fed with coffee
169Densitometer and the Quantity One program
(BioRad Laboratories, Hercules, CA, USA). Results
in duplicate were expressed as sample band intensity
(optical density of the band multiplied by the band
area) divided by control band intensity.
Statistical analysis
The MannWhitney non-parametric test was used
to compare the two coffee groups with the control
group. Tumour incidence in the colon was analysed
by Fisher’s exact test. The SPSS statistical program,
version 12 (SPSS Inc., Chicago, IL, USA), was used
for all statistical analysis. Differences were consid-
ered significant at pB0.05.
Results
Weight gain of the Apc
Min/ mice
Themicegrew wellduring thefeedingperiod andthe
weight gain and the final body weights of the
Apc
Min/ mice did not differ between the groups
(Fig. 1). At a few time points, coffee-fed mice had
slightly lower body weights than controls. The male
mice in the filtered coffee group had lower body
weights at the age of 11 weeks (pB0.05), and the
females in the unfiltered coffee group had lower
body weights at the ages of 7, 8, 9 and 10 weeks
(pB 0.05) compared with the control animals.
The authors suggest that these small differences in
body weights at certain time-points are not likely to
be biologically significant.
Adenoma results
The male and female Apc
Min/ mice did not differ
significantly in the number or diameter of adenomas
and therefore the data from male and female mice
were pooled. The range of adenoma number and
adenoma distribution between the small intestine
and the colon here were similar to those found in
other studies (25).
The tumour number or size in the small intestine
and the colon did not differ between dietary groups
(Table 2). The total tumour number was 29 for the
control group, 30 for the filtered coffee group and
29 for the unfiltered coffee group.
b-Catenin and cyclin D1 analysis
The subcellular localization, particularly nuclear
b-catenin and cyclin D1, is considered to be an
important determinant of their function. The effects
of coffee on b-catenin and cyclin D1 in tumours
were therefore analysed by a semi-quantitative
Western blot method. As observed in a previous
study (24), immunoblots of b-catenin gave one band
at 98 kDa in rat brain homogenate (control), and
one band (or two bands) at 92 kDa (full-length
b-catenin) in the adenoma tissue of Apc
Min/ mice
(Fig. 2A). The b-catenin results are expressed as
the intensity of the full-length band, which could be
detected in almost all samples. Immunoblots of
cyclin D1 gave one band at 35 kDa in the TMK
(a human gastric cancer cell) homogenate (control),
and two bands at 35 and 36 kDa, which probably
represent full-length cyclin D1 with different levels
of phosphorylation. The cyclin D1 results are
expressed as the intensity of these two bands. The
levels of nuclear b-catenin (Fig. 2B) and cyclin D1
(Fig. 2C) in the adenoma tissue did not differ
between the dietary groups.
Plasma xanthine analysis
Caffeine and its metabolites paraxanthine, theobro-
mine and theophylline were analysed from mouse
plasma samples. Paraxanthine was clearly the
dominant metabolite, and theophylline as well as
theobromine was present in minute amounts
only. Therefore, caffeine and paraxanthine were
used as markers of compliance. Plasma caffeine
and paraxanthine concentrations were 3.291.4 and
1.790.4 mmol l
1 in the filtered coffee group and
3.692.3 and 1.690.6 mmol l
1 in the unfiltered
coffee group. Xanthine concentrations in the con-
trol group were below the limit of quantification
Fig. 1. Mean body weights of multiple intestinal neoplasia
(Apc
Min/) males and females consuming the control, ﬁltered and
unﬁltered coffee diets for 9 weeks. 2: Control female; ": control
male; I: ﬁltered female; j: ﬁltered male; ^: unﬁltered female;
': unﬁltered male.
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respectively).
Discussion
To the authors’ knowledge, this is the first study
investigating the effects of filtered or unfiltered
coffee on adenoma formation in the Apc
Min/
mouse. The main difference between these two types
of coffee is the levels of kahweol and cafestol, which
are abundantly present only in unfiltered coffee.
Kahweol and cafestol have some bioactivity in the
human body, since unfiltered coffee has been
shown to raise serum cholesterol in man (26). In
the present study, filtered and unfiltered coffee
was evaluated for possible antitumorigenic activ-
ities. Consumption of a coffee-free diet, or filtered
or unfiltered coffee (10% w/w) for 9 weeks had a
similar effect on tumour formation in Apc
Min/
mice. Supplementation of the diet with coffee
increased significantly the levels of plasma caffeine
and paraxanthine in the plasma, indicating
good compliance with coffee supplementation.
The results show that filtered or unfiltered coffee,
their constituents (caffeine, kahweol and cafestol)
and the caffeine metabolite paraxanthine had no
chemoprotective effect in the Apc
Min/ mice. The
caffeine result is in line with another study with
Apc
Min/, which showed that administration of
caffeine at a dose of 0.044% in drinking fluid had
no inhibitory effect on tumour formation in this
animal model (9).
Even though the adenoma result did not differ
between the groups, the authors wanted to deter-
mine whether coffee changes the subcellular locali-
zation of b-catenin and its target protein cyclin D1,
since the improper regulation of cellular b-catenin
pools is one of the driving forces in Apc-induced
colonic neoplasia (18, 27). Dietary components
have been shown to affect b-catenin localization in
both the normal-appearing mucosa and the tumour
tissue, thus diminishing the progression of neoplasia
in Apc
Min/ mice (9, 28, 29). In the present study no
differences in the nuclear b-catenin and cyclin D1
levels were found between dietary groups, and
therefore it may be concluded that coffee consump-
tion does not affect cancer progression in the
adenoma tissue. However, these results do not
exclude the possibility that coffee consumption
has a protective effect against other type of cancers
in which the aetiology of the disease if different
Table 2. Tumour number, and size in the small intestine and the colon of Apc
Min/ mice fed with a control diet or diets supplemented with either ﬁltered or unﬁltered coffee
for 9 weeks
Control Filtered coffee Unfiltered coffee
Diet Median Range Median Range Median Range
n
a 11 11 11
Small intestine
Tumours per mouse 29 23202 29 15127 29 2166
p0.693 p0.430
Tumours per mouse
b 29 2365 29 1562 29 2166
p0.677 p0.646
Tumour size (mm) 1.1 1.01.4 1.2 0.71.4 1.1 0.91.4
p0.768 p0.768
Colon
Incidence 4/11 7/11 3/11
Tumours per mouse 0 021 0 40 0 2
p0.207 p0.811
Tumour size (mm) 3.0 1.74.1 2.9 2.04.0 2.4 2.33.3
p0.850 p0.593
Total
Tumours per mouse 29 25202 30 15131 29 2168
p0.767 p0.430
Results are expressed as median and range (minimummaximum). The MannWhitney non-parametric test was used to compare the filtered and unfiltered coffee groups
with the control group. Differences were considered significant at pB0.05.
aThe adenoma data from male (n7) and female (n4) mice were pooled.
bExclusion of two extreme values (202 and 127) from the control and filtered coffee groups, respectively, did not change the statistical significance between the groups.
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studies showed that coffee consumption decreased
the risk of liver cancer, although the exact mechan-
ism of action remained unclear (30, 31).
In the present study, caffeine and paraxanthine
were present in the plasma samples of all mice
receiving coffee, but not the controls. Paraxan-
thine appeared to be a good compliance marker
and, because of the smaller variation in para-
xanthine results, a better marker than plasma
caffeine. These findings are in line with those of
Klebanoff et al. (32), who suggested that plasma
paraxanthine reflects coffee consumption more
accurately than plasma caffeine in humans, owing
to its more favourable pharmacokinetic properties.
To the authors’ knowledge, this type of information
is not available from animal studies, although the
primary metabolism of caffeine, i.e. demethylation
by CYP1A2, has been extensively studied in many
species (33). The caffeine and paraxanthine con-
centrations were in the same range as those found
among the Finnish population (I. Erlund, unpub-
lished results). As the intake of coffee in the present
experiment was similar to the mean daily consump-
tion in Finnish adults, it may be concluded that
caffeine bioavailability is not dramatically different
in humans and in mice. Since weight gain was also
similar in the three different groups, non-compli-
ance cannot explain the results of the study.
In conclusion, this study found that filtered or
unfiltered coffee (10% w/w) does not exert anti-
tumorigenic activity in Apc
Min/ mice or change b-
catenin and cyclin D1 signalling in the adenoma
tissues.
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